Projects using StataProjects using StataFloral Illustrations and Pattern Design
I am a digital illustrator specializing in bold, lush floral artwork with a strong graphic edge. Working primarily in Krita, I create rich botanical compositions that blend realism with stylized illustration, making them perfect for art prints, textiles, wallpaper, packaging, and surface design.
Because of my background in business, marketing, and commercial design, I do not just create visually striking art. I design with real-world application, print specs, and brand strategy in mind to ensure market-ready results.
Featured Works
"Crimson Bloom": A dramatic, structured red floral centerpiece surrounded by deep foliage and glistening dewdrop accents. Built around bold contrast, tactile texture, and a rich, grounded natural palette.
"Midnight Iris": Two striking violet-blue irises emerging from a dense layer of monstera and structured sword leaves. Focuses on cool tones, intricate line work, and high-contrast atmospheric lighting.
Signature Style and Approach
My botanical work captures the vitality and drama of nature while maintaining a clean, decorative aesthetic that translates seamlessly into both standalone art prints and repeat patterns. Every piece balances organic geometry, intricate leaf structures, and rich lighting dynamics, built from the ground up to drive real commercial value for your brand.
Ways We Can Collaborate:
Standalone Art Prints and Posters
Seamless Pattern Designs (Fabric, Wallpaper, Textiles)
Custom Botanical and Floral Illustrations
Commercial Work and Packaging Design
Interested in working together? Send over a message or project brief. I would love to bring this same vibrant, nature-inspired energy to your next project. IAbstract. Stem cell (SC) transplantation has shown potential as a therapeutic approach for premature ovarian failure (POF). Despite this, no quantitative analysis has been conducted on the efficacy of SC therapy for POF in humans. To address this gap, the present study conducted a meta-analysis to evaluate the effectiveness of the transplantation of SC in improving ovarian function among POF patients. A systematic review in this regard by searching PubMed, ScienceDirect, clinicalTrial.gov (http://clinicalTrial.gov), and Cochrane's library databases was conducted to identify relevant studies, while associated reviews were also considered. The extracted data included parameters such as estradiol (E2), follicle-stimulating hormone (FSH), follicle count (FC), ovarian weight (OW), number of pregnancies, and live birth. As per the combined effect taking the last follow-up time, the level of FSH and AMH for the SC group was lower than these were at the baseline as (SMD: 1.58, 95% CI: 0.76 to 3.92, P-value: 0.185 > 0.05, I2 : 94.03%) and (SMD: 1.34, 95% CI: 0.77 to 1.92, P-value: 0.001 < 0.05, I2 : 0%) respectively. While the means of E2 and OW for the SC group was higher than these were at the baseline as (SMD: 0.47, 95% CI: 0.73 to 0.21, P-value: 0.001 < 0.01, I2 : 38.23%) and (SMD: 1.18, 95% CI: 2.62 to 0.26, P-value: 0.108 > 0.05, I2 : 76.68%) respectively. The overall effect size measured with proportion of pregnancy and live birth at a 5% level of significance expected SC transplantation results were as (combined proportion: 0.09, 95% CI: 0.03 to 0.15, P-value: 0.002 < 0.05, I2 : 46.29%) and (SMD: 0.09, 95% CI: 0.03 to 0.15, P-value: 0.003 < 0.05, I2 : 1.76%) respectively. Based on the fixed-effects model, the estimated average log odds ratio of Follicles count was 1.0234 (95% CI: 0.1252 to 1.9216). Therefore, the average outcome differed significantly from zero (Pvalue: 0.0255 < 0.05) due to SC transplantation. These results suggest that using SCs to restore ovarian function may be viable for treating POF. However, larger and better-quality investigations would need to be conducted in the future due to the heterogeneity of the examined studies. 
